Sunday, June 21, 2026

Patent directory · USPTO A61K / A61P

Browse patents

Browse 30,257 pharma-relevant patents (US A61K/A61P) linked to tracked companies, drugs, and pipeline programs.

Patents indexed 30,257
Companies 1,769
Drugs linked 4,797

Quick answer

NovaPharmaNews indexes 30,257 US pharmaceutical patents from USPTO PatentsView (CPC A61K/A61P), cross-linked to company assignees, drug INN profiles, and pipeline programs. Search by patent number, applicant, title, or CPC code — or use facet hubs for expiring patents, assignees, and therapeutic areas.

Patent results

Page 1114 of 1,261
  1. AU 2001281846

    Method for preparing a composition

    CHEPLAPHARM ARZNEIMITTEL GMBH [DE] · Granted Apr 27, 2006 · Expires Apr 22, 2026

    expired
  2. US 7034016

    8-phenyl-6,9-dihydro-[1,2,4]triazolo[3,4-i]purin-5-one derivatives

    Almirall Prodesfarma S.A. · Granted Apr 25, 2006 · Expires Apr 20, 2026

    expired
  3. US 7033750

    Recombinant P53 adenovirus methods and compositions

    The Board of Regents of the University of Texas System · Granted Apr 25, 2006 · Expires Apr 20, 2026

    expired
  4. US 7033603

    Drug releasing biodegradable fiber for delivery of therapeutics

    The Board of Regents of the University of Texas · Granted Apr 25, 2006 · Expires Apr 20, 2026

    expired
  5. US 7033608

    “Burst-free” sustained release poly-(lactide/glycolide) microspheres

    The United States of America as represented by the Secretary of the Army · Granted Apr 25, 2006 · Expires Apr 20, 2026

    expired
  6. US 7033582

    Use of glatiramer acetate (copolymer 1) in the treatment of central nervous system disorders

    TEVA PHARMACEUTICAL INDUSTRIES, LTD. · Granted Apr 25, 2006 · Expires Apr 20, 2026

    expired
  7. US 7034056

    Aryl and biaryl compounds having MCH modulatory activity

    Pharmacopeia Drug Discovery, Inc. · Granted Apr 25, 2006 · Expires Apr 20, 2026

    expired
  8. US 7034048

    Gastrin and cholecystokinin receptor ligands (III)

    The James Black Foundation Limited · Granted Apr 25, 2006 · Expires Apr 20, 2026

    expired
  9. US 7034118

    Corticotropin-releasing factor2 receptors

    Neurocrine Biosciences, Inc. · Granted Apr 25, 2006 · Expires Apr 20, 2026

    expired
  10. US 7034039

    Fused heterocyclic compounds

    Takeda Pharmaceutical Company Limited · Granted Apr 25, 2006 · Expires Apr 20, 2026

    expired
  11. US 7034014

    Phosphonate compounds

    The Regents of the University of California · Granted Apr 25, 2006 · Expires Apr 20, 2026

    expired
  12. US 7033771

    Use of insulin response modulators in the treatment of diabetes and insulin resistance

    Takeda Pharmaceutical Company Limited · Granted Apr 25, 2006 · Expires Apr 20, 2026

    expired
  13. US 7033620

    Product and process for stabilizing Aloe vera gel

    Aloe Vera of America, Inc. · Granted Apr 25, 2006 · Expires Apr 20, 2026

    expired
  14. US 7029685

    Plasmodium falciparum AMA-1 protein and uses thereof

    The United States of America as represented by the Secretary of the Army · Granted Apr 18, 2006 · Expires Apr 13, 2026

    expired
  15. US 7029899

    Selective toxicity of amino-terminal modified rnase a superfamily polypeptides

    The United States of America, as represented by the Department of Health and Human Services · Granted Apr 18, 2006 · Expires Apr 13, 2026

    expired
  16. US 7030278

    Polyethylene(Glycol) derivatives with proximal reactive groups

    Nektar Therapeutics AL, Corporation · Granted Apr 18, 2006 · Expires Apr 13, 2026

    expired
  17. US 7030232

    E25A protein, methods for producing and use thereof

    The Regents of the University of California · Granted Apr 18, 2006 · Expires Apr 13, 2026

    expired
  18. US 7030087

    Synthetic approach to designed chemical structures

    Regents of the University of Minnesota · Granted Apr 18, 2006 · Expires Apr 13, 2026

    expired
  19. US 7029838

    Prevascularized contructs for implantation to provide blood perfusion

    Arizona Board of Regents on Behalf of the University of Arizona · Granted Apr 18, 2006 · Expires Apr 13, 2026

    expired
  20. US 7030080

    Lymphotoxin-β, lymphotoxin-β complexes, pharmaceutical preparations and therapeutic uses thereof

    The Regents of the University of California · Granted Apr 18, 2006 · Expires Apr 13, 2026

    expired
  21. US 7029911

    AFC1 and RCE1: isoprenylated CAAX processing enzymes

    The Regents of the University of California · Granted Apr 18, 2006 · Expires Apr 13, 2026

    expired
  22. US 7030231

    Membrane type serine protease 1 (MT-SP1) and uses thereof

    Catalyst Biosciences, Inc. · Granted Apr 18, 2006 · Expires Apr 13, 2026

    expired
  23. US 7029696

    Delivery and activation through liposome incorporation of diaminocyclohexane platinum(II) complexes

    The Board of Regents of the University of Texas System · Granted Apr 18, 2006 · Expires Apr 13, 2026

    expired
  24. US 7029652

    Method of treating tumors

    The Regents of the University of California · Granted Apr 18, 2006 · Expires Apr 13, 2026

    expired

Frequently asked questions

What patents are included in this directory?

We index 30,257 published US pharma-relevant patents filtered to CPC classes A61K and A61P, with assignee links to our company directory where a match exists.

How do I search for a patent?

Use the search box to match patent number, title, applicant name, or CPC classification (e.g. A61K). For cross-entity queries spanning news and drugs, use the global search.

How is this different from the patent intelligence dashboard?

The dashboard at /patents highlights expirations, recent grants, and assignee rankings. Browse is the full paginated directory with search — best for looking up a specific filing or applicant portfolio slice.